ScienceNews Science News By Dehui Huang on Friday, November 20, 2026 Nature Medicine, Published online: 20 November 2026; doi:10.1038/s41591-026-04782-z Reply to: Concerns about use of placebo control in clinical trials of Obinutuzumab β for aquaporin-4 antibody positive neuromyelitis optica spectrum disorder Read More Previous Post Next Post Related Posts ScienceNews Science News ScienceNews Science News ScienceNews Science News